DOCSLIB.ORG

Dose-Response Curves (1)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dose-Response Curves (1) Chapter 4 The Dose-Response Relationship Introduction • The need to establish some criteria to base the relative safety of chemicals is essential. • Several methods are used to obtain data in order to establish safe levels and provide information about the relative toxicity of chemicals. Acute Toxicological Studies (1) • Information concerning the toxicity of a substance is obtained primarily from either acute or chronic toxicity studies. • Acute toxicity studies are the most commonly performed studies for obtaining information on the effects of chemical exposure. They are short-term, relatively inexpensive tests with death of the test animal being the useful observed effect. • Information obtained from acute toxicity tests can be used to – determine the relative toxicity of different chemicals comparing the respective LD50 values, which are the doses that prove to be lethal for 50 percent of the test animals; – identify the target organs (heart, liver, kidneys, etc.) that are affected as a result of exposure; and – determine the appropriate doses for long term, chronic studies. Acute Toxicological Studies (2) • To perform acute toxicity studies the test animal population is divided into several groups, with an equal number of individuals (usually 10 to 50) in each group. One group of test animals –referred to as the control group – is exposed to all the same experimental conditions except exposure to the toxic substance. • The groups are observed for 14 days, and the number of deaths in each group is recorded. Acute Toxicological Studies (3) • LC50 is a measure of chemical toxicity resulting from inhalation. LC means “lethal concentration” and the subscript has the same meaning as described previous for LD. The unit of measure for the LC50 is usually expressed as part per million (ppm). Chronic Toxicological Studies (1) • Chronic toxicity tests may be performed over a period of months, years, or the lifetime of the test animal. Doses of the toxic substance are selected to assure that most of the animals will survive the entire time the study is performed. • Different species of test animals may be more or less sensitive to the same toxic chemical. • Males and females of the same species may respond differently to the same substance. • Although acute and chronic studies provide useful information in evaluating chemical toxicity, it is important to understand that they are not truly representative of the environment to which people are exposed in everyday life. Chronic Toxicological Studies (2) • Characteristics of animal studies – A single dose – A single route of exposure – The number of animals exposed is small. – The genetic make-up of the population is not very diverse. – Only individuals in good health and/or of the same sex are selected. • In reality – Several different routes – Exposure to more than one chemical at a time – Greater genetic variability in a larger population – the range of responses to a given chemicals more diverse. – The collective interactive effect of all these factors on toxicity makes it difficult to establish a cause-effect relationship. Dose-Response Curves (1) • The major purpose for performing acute and chronic toxicity studies is to establish a cause-effect relationship between exposure to a toxic substance and an observed effect in order to determine a safe exposure level. • A curve can be drawn that illustrates the relationship between the dose administered and the observed response. This curve is referred to as the dose-response curve. • A dose-response curve can be developed form most chemicals. From these curves the threshold level and the relative toxicity of chemicals can be obtained to help establish safe levels of chemical exposure. Dose-Response Curves (2) • The threshold is the dose below which no effect is detected or above which an effect is first observed. • The threshold information is useful information in extrapolating animal data to humans and calculating what may be considered a safe human dose for a given toxic substance. • The threshold dose (ThD0.0) is measured as mg/kg/day. It is assumed that humans are as sensitive as the test animal used. To determine the equivalent dose in man the ThD0.0 is multiplied by the average weight of a man, which is considered to be 70 kg. Dose-Response Curves (3) • The calculation used to determine the safe human dose (SHD) is as follows: ThD 70 (kg) SHD 0.0 Amount mg/day of toxic substance SF Where SHD = Safe Human Dose ThD0.0 = Threshold dose at which no effect is observed. 70 Kg = Average weight of a man SF = Safety factor (ranges from 10 to 1000, which varies according to the type of test and data used to obtain the ThD0.0. Terminology Associated with Dose-Response Curves (1) • No observed effect level (NOEL) – The highest tested dose of a substance that has been reported to have no harmful (adverse) health effects on people or animals. • No observed adverse effect level (NOAEL) – It denotes the level of exposure of an organism, found by experiment or observation, at which there is no biologically or statistically significant (e.g. alteration of morphology, functional capacity, growth, development or life span) increase in the frequency or severity of any adverse effects in the exposed population when compared to its appropriate control. Terminology Associated with Dose-Response Curves (2) • lowest-observed-effect-level (LOEL) – Lowest concentration or amount of a substance, found by experiment or observation, that causes any alteration in morphology, functional capacity, growth, development, or life span of target organisms distinguishable from normal (control) organisms of the same species and strain under the same defined conditions of exposure • lowest-observed-adverse-effect-level (LOAEL) – Lowest concentration or amount of a substance, found by experiment or observation, which causes an adverse alteration of morphology, functional capacity, growth, development, or life span of a target organism distinguishable from normal (control) organisms of the same species and strain under defined conditions of exposure. Terminology Associated with Dose-Response Curves (3) • Frank-effect level (FEL) – Level of exposure that produces unmistakable and irreversible effects (such as impairment or mortality) at statistically significant increased severity or frequency. – The level where overt effects are observed is referred to as the Frank-effect level. Threshold Dose • Dose below which no adverse effects are observable in a population of exposed individuals. • Threshold dose approximated by a NOAEL (No Observed Adverse Effect Level) Non-threshold Effects • Thresholds are assumed not to exist for genotoxic carcinogens Safe Dose for Threshold Effect • NOAEL approach – Identify the adverse effect that occurs at the lowest dose – Determine the NOAEL or LOAEL for that endpoint – Divide NOAEL/LOAEL by uncertainty factors Acceptable Daily Intake • ADI estimated (maximum) amount of an agent, expressed on a body mass basis, to which a subject may be exposed over his lifetime without appreciable health risk (also TDI, tolerable daily intake) • ADI derived from NOAEL by the use of uncertainty factors UFs (or safety factors SFs) Reference Dose (RfD) • RfD is an estimate of the daily exposure that is likely to be without appreciable health effect even if continued exposure occurs over a lifetime. Uncertainty Factors • Default values: UFinterspecies = 10 , UFhuman variability = 10 Additional Uncertainty Factors • Sometimes applied: – UFLOAEL-NOAEL = 3 or 10 – UFsubchronic-chronic = 3 or 10 – UF database insufficiences = up to 10 • MF, modifying factor for professional judgement: up to 10 • RfD = NOAEL (or LOAEL) / UF1 UF2 UF3 MF Benchmark Dose Approach (1) • NOAEL approach uses only single points, shape of dose-response is ignored. • Bench mark dose (BMD) is calculated from the curve fitted to the dose-reponse data, so all information is used. • BMD can only be used when available data are suitable for modelling. • Not replacement for NOAEL, but additional tool Benchmark Dose Approach (2) 1. A mathematical model is applied to the experimental data to produce a dose-response curve of best fit. 2. By statistical calculation an upper 95% confidence limit of the curve is determined 3. The Benchmark Response is defined as 10% (or 5%, or 1%). 4. The Benchmark Dose corresponds to the bench mark response on the upper confidence limit curve. Benchmark Dose Approach (3) Non-threshold? • Absence of a detectable effect at low doses is either because the dose is below a threshold or because the response is below the level that can be detected by the test sytem. Threshold or Non-threshold • Presence of a threshold cannot be proven from experimental data. • Conclusions about existence of a threshold are based on biological plausibility and expert judgement. • Genotoxic effects (DNA dammage leading to cancer) are thought to be possible at any level of exposure, so no threshold. Low-dose Extrapolation • Dose-response curve is use to extrapolate to doses lower than then the experimental region. Calculated Risk or Safe Dose • Extrapolation may be used to calculate: – the risk associated with a known intake. – intake associated with a de minimis risk, e.g. an increased life time risk of developing cancer of 1 in 106 (‘virtually safe dose’, VSD). Linear Low-dose Extrapolation • Assumption: linear relationship between dose and biological response Linear Extrapolation from LED10 • LED10 – low confidence limit of dose with response of 10% From LED10 to VSD • If LED10 = 57 mg/kg/day (response 10% or 0,1) • then VSD (virtual safe dose, response 1 in 106 or 10-6) = 57 x 10-6 / 0,1 = 5,7 x 10-4 mg/kg/day ALARA Approach • For genotoxic carcinogens (non-threshold effects) also the ALARA-approach may be followed: exposure to be reduced to as low as reasonably achievable (ALARA) or as low as reasonably practical (ALARP) Relative Toxicity (1) • A comparison of the dose-response curves for two or more different chemicals – administered to the same type of test animal – can be used to determine the relative toxicity of the chemicals.
Load more

Recommended publications
  • Exposure to Carcinogens and Work-Related Cancer: a Review of Assessment Methods
    European Agency for Safety and Health at Work ISSN: 1831-9343 Exposure to carcinogens and work-related cancer: A review of assessment methods European Risk Observatory Report Exposure to carcinogens and work-related cancer: A review of assessment measures Authors: Dr Lothar Lißner, Kooperationsstelle Hamburg IFE GmbH Mr Klaus Kuhl (task leader), Kooperationsstelle Hamburg IFE GmbH Dr Timo Kauppinen, Finnish Institute of Occupational Health Ms Sanni Uuksulainen, Finnish Institute of Occupational Health Cross-checker: Professor Ulla B. Vogel from the National Working Environment Research Centre in Denmark Project management: Dr Elke Schneider - European Agency for Safety and Health at Work (EU-OSHA) Europe Direct is a service to help you find answers to your questions about the European Union Freephone number (*): 00 800 6 7 8 9 10 11 (*) Certain mobile telephone operators do not allow access to 00 800 numbers, or these calls may be billed. More information on the European Union is available on the Internet ( 48TU http://europa.euU48T). Cataloguing data can be found on the cover of this publication. Luxembourg: Publications Office of the European Union, 2014 ISBN: 978-92-9240-500-7 doi: 10.2802/33336 Cover pictures: (clockwise): Anthony Jay Villalon (Fotolia); ©Roman Milert (Fotolia); ©Simona Palijanskaite; ©Kari Rissa © European Agency for Safety and Health at Work, 2014 Reproduction is authorised provided the source is acknowledged. European Agency for Safety and Health at Work – EU-OSHA 1 Exposure to carcinogens and work-related cancer:
    [Show full text]
  • Carcinogens Are Mutagens
    -Proc. Nat. Acad. Sci. USA Vol. 70, No. 8, pp. 2281-2285, August 1973 Carcinogens are Mutagens: A Simple Test System Combining Liver Homogenates for Activation and Bacteria for Detection (frameshift mutagens/aflatoxin/benzo(a)pyrene/acetylaminofluorene) BRUCE N. AMES, WILLIAM E. DURSTON, EDITH YAMASAKI, AND FRANK D. LEE Biochemistry Department, University of California, Berkeley, Calif. 94720 Contributed by Bruce N. Ames, May 14, 1973 ABSTRACT 18 Carcinogens, including aflatoxin Bi, methylsulfoxide (Me2SO), spectrophotometric grade, was ob- benzo(a)pyrene, acetylaminofluorene, benzidine, and di- tained from Schwarz/Mann, sodium phenobarbital from methylamino-trans-stilbene, are shown to be activated by liver homogenates to form potent frameshift mutagens. Mallinckrodt, aflatoxin B1 from Calbiochem, and 3-methyl- We believe that these carcinogens have in common a ring cholanthrene from Eastman; 7,12-dimethylbenz(a)anthracene system sufficiently planar for a stacking interaction with was a gift of P. L. Grover. Schuchardt (Munich) was the DNA base pairs and a part of the molecule capable of being source for the other carcinogens. metabolized to a reactive group: these structural features are discussed in terms of the theory of frameshift muta- Bacterial Strains used are mutants of S. typhimurium LT-2 genesis. We propose that these carcinogens, and many have been discussed in detail others that are mutagens, cause cancer by somatic muta- and (2). tion. A simple, inexpensive, and extremely sensitive test for Source Liver. Male rats (Sprague-Dawley/Bio-1 strain, detection of carcinogens as mutagens is described. It con- of sists of the use of a rat or human liver homogenate for Horton Animal Laboratories) were maintained on Purina carcinogen activation (thus supplying mammalian metab- laboratory chow.
    [Show full text]
  • Toxicological Profile for Radon
    RADON 205 10. GLOSSARY Some terms in this glossary are generic and may not be used in this profile. Absorbed Dose, Chemical—The amount of a substance that is either absorbed into the body or placed in contact with the skin. For oral or inhalation routes, this is normally the product of the intake quantity and the uptake fraction divided by the body weight and, if appropriate, the time, expressed as mg/kg for a single intake or mg/kg/day for multiple intakes. For dermal exposure, this is the amount of material applied to the skin, and is normally divided by the body mass and expressed as mg/kg. Absorbed Dose, Radiation—The mean energy imparted to the irradiated medium, per unit mass, by ionizing radiation. Units: rad (rad), gray (Gy). Absorbed Fraction—A term used in internal dosimetry. It is that fraction of the photon energy (emitted within a specified volume of material) which is absorbed by the volume. The absorbed fraction depends on the source distribution, the photon energy, and the size, shape and composition of the volume. Absorption—The process by which a chemical penetrates the exchange boundaries of an organism after contact, or the process by which radiation imparts some or all of its energy to any material through which it passes. Self-Absorption—Absorption of radiation (emitted by radioactive atoms) by the material in which the atoms are located; in particular, the absorption of radiation within a sample being assayed. Absorption Coefficient—Fractional absorption of the energy of an unscattered beam of x- or gamma- radiation per unit thickness (linear absorption coefficient), per unit mass (mass absorption coefficient), or per atom (atomic absorption coefficient) of absorber, due to transfer of energy to the absorber.
    [Show full text]
  • Cancer Cause: Biological, Chemical and Physical Carcinogens
    Merit Research Journal of Medicine and Medical Sciences (ISSN: 2354-323X) Vol. 6(9) pp. 303-306, September, 2018 Available online http://www.meritresearchjournals.org/mms/index.htm Copyright © 2018 Merit Research Journals Review Cancer Cause: Biological, Chemical and Physical Carcinogens Asst. Prof. Dr. Chateen I. Ali Pambuk* and Fatma Mustafa Muhammad Abstract College of Dentistry / University of Cancer arises from abnormal changes of cells that divide without control Tikrit and are able to spread to the rest of the body. These changes are the result of the interaction between the individual genetic factors and three *Corresponding Author Email: categories of external factors: a chemical carcinogens, radiation, hormonal [email protected]. imbalance, genetic mutations and genetic factors. Genetic deviation leads to Mobile phone No. 009647701808805 the initiation of the cancer process, while the carcinogen may be a key component in the development and progression of cancer in the future. Although the factors that make someone belong to a group with a higher risk of cancer, the majority of cancers actually occur in people who do not have known factors. The aim of this descriptive mini-review, generally, is to shed light on the main cause of cancer and vital factors in cellular system and extracellular system that may be involved with different types of tumors. Keywords: Cancer, Cancer cause, physical Carcinogens, Chemical carcinogens, biological carcinogens INTRODUCTION Carcinogen is any substance (radioactive or radiation) .Furthermore, the chemicals mostly involve as the that is directly involved in the cause of cancer. This may primary cause of cancer, from which dioxins, such as be due to the ability to damage the genome or to disrupt benzene, kibon, ethylene bipromide and asbestos, are cellular metabolism or both rendering the cell to be classified as carcinogens (IUPAC Recommendations, sensitive for cancer development.
    [Show full text]
  • Radiation and Your Patient: a Guide for Medical Practitioners
    RADIATION AND YOUR PATIENT: A GUIDE FOR MEDICAL PRACTITIONERS A web module produced by Committee 3 of the International Commission on Radiological Protection (ICRP) What is the purpose of this document ? In the past 100 years, diagnostic radiology, nuclear medicine and radiation therapy have evolved from the original crude practices to advanced techniques that form an essential tool for all branches and specialties of medicine. The inherent properties of ionising radiation provide many benefits but also may cause potential harm. In the practice of medicine, there must be a judgement made concerning the benefit/risk ratio. This requires not only knowledge of medicine but also of the radiation risks. This document is designed to provide basic information on radiation mechanisms, the dose from various medical radiation sources, the magnitude and type of risk, as well as answers to commonly asked questions (e.g radiation and pregnancy). As a matter of ease in reading, the text is in a question and answer format. Interventional cardiologists, radiologists, orthopaedic and vascular surgeons and others, who actually operate medical x-ray equipment or use radiation sources, should possess more information on proper technique and dose management than is contained here. However, this text may provide a useful starting point. The most common ionising radiations used in medicine are X, gamma, beta rays and electrons. Ionising radiation is only one part of the electromagnetic spectrum. There are numerous other radiations (e.g. visible light, infrared waves, high frequency and radiofrequency electromagnetic waves) that do not posses the ability to ionize atoms of the absorbing matter.
    [Show full text]
  • New Discoveries in Radiation Science
    cancers Editorial New Discoveries in Radiation Science Géza Sáfrány 1,*, Katalin Lumniczky 1 and Lorenzo Manti 2 1 Department Radiobiology and Radiohygiene, National Public Health Center, 1221 Budapest, Hungary; [email protected] 2 Department of Physics, University of Naples Federico II, 80126 Naples, Italy; [email protected] * Correspondence: [email protected]; Tel.: +36-309199218 This series of 16 articles (8 original articles and 8 reviews) was written by internation- ally recognized scientists attending the 44th Congress of the European Radiation Research Society (Pécs, Hungary). Ionizing radiation is an interesting agent because it is used to cure cancers and can also induce cancer. The effects of ionizing radiation at the organism level depend on the response of the cells. When radiation hits a cell, it might damage any cellular organelles and macromolecules. Unrepairable damage leads to cell death, while misrepaired alterations leave mutations in surviving cells. If the repair is errorless, normal cells will survive. However, in a small percentage of the seemingly healthy cells the number of spontaneous mutations will increase, which is a sign of radiation-induced genomic instability. Radiation-induced cell death is behind the development of acute radiation syndromes and the killing of tumorous and normal cells during radiation therapy. Radiation-induced mutations in surviving cells might lead to the induction of tumors. According to the central paradigm of radiation biology, the genetic material, that is the DNA, is the main cellular target of ionizing radiation. Many different types of damage are induced by radiation in the DNA, but the most deleterious effects arise from double strand breaks (DSBs).
    [Show full text]
  • Reducing Risks to Students and Educators from Hazardous Chemicals in a Secondary School Chemical Inventory
    Reducing Risks to Students and Educators from Hazardous Chemicals in a Secondary School Chemical Inventory Introduction The need to properly educate young people in the sciences, especially in chemistry, brings challenges to educators that encompass a vast array of school policies, the safety of the students and faculties, the protection of the environment and associated regulatory compliance issues. The American Chemical Society’s Joint Board-Council Committee on Chemical Safety (CCS) was formed to help members understand the importance of safety in the handling and use of chemicals. The Safe Practices Subcommittee of CCS, in preparing this document, examined safety in the handling and use of chemicals as a risk issue to children, as well as educators, in secondary schools only. The work presented here was based on the following observations and conclusions: o ACS members who are secondary school educators have requested information regarding aging chemical inventories and appropriate chemicals for secondary school education. o Chemical inventories found in high schools contain a vast array of chemicals ranging from safe and suitable for education at the secondary level to extremely hazardous, unsuitable and inappropriate for those unknowledgeable or untrained in their use and potentially harmful to the environment. o The secondary school populations represent our finest young minds and also our least knowledgeable and skilled in laboratory science. o It is important that our students receive a solid education in chemical science that can only be achieved by using chemicals in the laboratory through safe and effective laboratory experiences. o Minimizing risks to students from extremely hazardous chemicals at this early stage of science learning is a prudent approach in the educational process.
    [Show full text]
  • Chemicals, Cancer, and You
    Chemicals, Cancer, and You There are many risk factors for cancer: age, family history, viruses and bacteria, lifestyle (behaviors), and contact with (touching, eating, drinking, or breathing) harmful substances. More than 100,000 chemicals are used by Americans, and about 1,000 new chemicals are introduced each year. These chemicals are found in everyday items, such as foods, personal products, packaging, prescription drugs, and household and lawn care products. While some chemicals can be harmful, not all contact with chemicals is dangerous to your health. This booklet will discuss the relationship between contact with harmful chemicals, cancer, and you. It will explain risk factors (things that make you likelier to get cancer), how cancer develops, and how contact with (exposure to) chemicals affects your body. Agency for Toxic Substances and Disease Registry Division of Health Assessment and Consultation CS218078-A 1 Chemicals, Cancer, and You Some factors that increase your risk of developing cancer include behaviors such as smoking, heavy alcohol Examples of Known Human Carcinogens consumption, on-the-job exposure to chemicals, radiation and sun exposure, and some viruses and bacteria. When all these risks are considered together, the role of chemical • Asbestos exposures in causing cancer is small and, as of now, not very clear. Scientists know very little about how contact with • Arsenic most chemicals causes cancer. • Benzene Substances known to cause cancer are called carcinogens. Coming into contact with a carcinogen does not mean you • Beryllium will get cancer. It depends on what you were exposed to, how often you were exposed, and how much you were • Vinyl chloride exposed to, among other things.
    [Show full text]
  • Carcinogens and Mutagens Fact Sheet
    Carcinogens and Mutagens Fact Sheet This fact sheet is for general safety awareness. Individual Standard Operating Procedures for all experiments and processes involving carcinogens or mutagens must be developed by the laboratory. PROPERTIES & HAZARDS Carcinogens are chemicals that are known or suspected to cause cancer in humans. Cancer is a chronic effect and is typically the result of repeated or long-term exposure. Symptoms may develop many years after exposure. A known human carcinogen means there is sufficient evidence of a cause and effect relationship between exposure to the material and cancer in humans. A substance that has induced cancer in experimental animal studies is referred to as a suspected human carcinogen. Mutations are defined as causing a permanent change in the amount or structure of the genetic material in a cell. The term mutation applies both to heritable genetic changes that may be manifested at the phenotypic level and to the underlying DNA modifications when known. This hazard class is primarily concerned with chemicals that may cause mutations in the germ cells of humans that can be transmitted to the progeny. However, mutagenicity/genotoxicity tests in vitro and in mammalian somatic cells in vivo are also considered in classifying substances and mixtures within this hazard class. There are three categories for carcinogens and mutagens, Category 1A, 1B and 2, that you may see on the safety data sheet (SDS) or chemical bottle. In Section 2 – Hazard Identification of the SDS, a combination of the following hazard classifications, pictograms and hazard statements will be listed indicating a carcinogen or mutagen hazard.
    [Show full text]
  • Guidelines for Carcinogen Risk Assessment
    EPA/630/P-03/001B March 2005 Guidelines for Carcinogen Risk Assessment Risk Assessment Forum U.S. Environmental Protection Agency Washington, DC DISCLAIMER Mention of trade names or commercial products does not constitute endorsement or recommendation for use. CONTENTS 1. INTRODUCTION ........................................................ 1-1 1.1. PURPOSE AND SCOPE OF THE GUIDELINES ........................ 1-1 1.2. ORGANIZATION AND APPLICATION OF THE GUIDELINES ........... 1-3 1.2.1. Organization .............................................. 1-3 1.2.2. Application ............................................... 1-5 1.3. KEY FEATURES OF THE CANCER GUIDELINES ..................... 1-7 1.3.1. Critical Analysis of Available Information as the Starting Point for Evaluation ............................................... 1-7 1.3.2. Mode of Action ........................................... 1-10 1.3.3. Weight of Evidence Narrative ............................... 1-11 1.3.4. Dose-response Assessment .................................. 1-12 1.3.5. Susceptible Populations and Lifestages ........................ 1-13 1.3.6. Evaluating Risks from Childhood Exposures .................... 1-15 1.3.7. Emphasis on Characterization ............................... 1-21 2. HAZARD ASSESSMENT .................................................. 2-1 2.1. OVERVIEW OF HAZARD ASSESSMENT AND CHARACTERIZATION . 2-1 2.1.1. Analyses of Data ........................................... 2-1 2.1.2. Presentation of Results ...................................... 2-1 2.2.
    [Show full text]
  • Definitions for SDS
    Definitions for SDS Action levels - levels of exposure (concentration in air) at which OSHA regulations for protective programs must be put into effect. Acute toxicity - ability of a substance to cause poisonous effects resulting in severe biological harm or death soon after a single exposure or dose. Ambient - encompassing atmosphere. American Conference of Governmental Industrial Hygienists (ACGIH) - professional organization devoted to worker health protection and develops threshold limit values for chemical substances. American National Standards Institute (ANSI) - body of various trade, technical, professional, and consumer groups whom develop voluntary ANSI standards. American Society for Testing and Materials (ASTM) - voluntary membership organization with members from a broad spectrum of individuals and agencies that sample and test methods on materials to determine the health and safety aspects of materials, safe performance guidelines, and effects of physical and biological agents and chemicals. Article - manufactured item other than fluid or particle: (i) which is formed to a specific shape or design during manufacture; (ii) which has end use function(s) dependent in whole or in part upon its shape or design during end use; and (iii) which under normal conditions of use does not release more than very small quantities, e.g., minute or trace amounts of a hazardous chemical and does not pose a physical hazard or health risk to workers. Carcinogen - a chemical is considered to be a carcinogen if: • it has been evaluated by the International Agency for Research on Cancer (IARC), and found to be a carcinogen or potential carcinogen, • it is listed as a carcinogen or potential carcinogen in the Annual Report on Carcinogens published by the National Toxicology Program (NTP) (latest edition), • it is regulated by OSHA as a carcinogen.
    [Show full text]
  • Occupational Cancer - Prevention and Control
    OCCUPATIONAL SAFETY AND HEALTH SERIES No. 33 OCCUPATIONAL CANCER - PREVENTION AND CONTROL INTERNATIONAL LABOUR OFFICE - GENEVA ISBN 92-2-101827-X First published 1977 The designations employed in ILO publications, which are in conformity with United Nations practice, and the presentation of material therein do not imply the expression of any opinion whatsoever on the part of the International Labour Office concerning the legal status of any country or territory or of its authorities, or concerning the delimitation of its frontiers. The responsibility for opinions expressed in signed articles, studies and other contributions rests solely with their authors, and publication does not constitute an endorsement by the International Labour Office of the opinions expressed in them. ILO publications can be obtained through major booksellers or ILO local offices in many countries, or direct from ILO Publications, International Labour Office, CH-1211 Geneva 22, Switzerland. A catalogue or list of new publications will be sent free of charge from the above address. Printed by the International Labour Office, Geneva. Switzerland. CONTENTS £âSÊ FOREWORD 1 1. PROBLEMS RELATING TO THE ESTABLISHHENT OF OCCUPATIONAL STANDARDS FOR CARCINOGENS 3 1.1 Animal experimentation 3 1.2 Extrapolation from animal to man 5 1.3 Epidemiological studies 7 1.4 New chemicals and chemicals in use 8 2. CLASSIFICATION OF CARCINOGENS FOR THE PURPOSE OF LEGISLATION 10 3. PREVENTIVE MEASURES 13 3.1 General principles 13 3.2 Technical measures 14 3.3 Personal protective measures 16 3.4 Emergencies 17 4. EXPOSURE MONITORING 18 4.1 Workplace monitoring 18 4.2 Biological monitoring 19 5.
    [Show full text]